Astellas Pharma Inc. - Change In Cash

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-In-Cash" stands at -87.53 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Astellas Pharma Inc.'s first quarter result of 27.03 Billion JPY for the item "Change In Cash" represents an increase of 217.70 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of 27.03 Billion JPY for the item "Change In Cash" represents an increase of 182.50 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of -87.53 Billion JPY for the item "Change In Cash" represents an increase of 40.58 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 171.03 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 171.03 Billion Japanese Yens.
The 3 year change is -98.62 Billion Japanese Yens.
The 5 year change is -68.04 Billion Japanese Yens.
The 10 year change is -86.05 Billion Japanese Yens.

The Serie's long term average value is -2.84 Billion Japanese Yens. It's latest available value, on 06/30/2025, is -84.69 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is +171.03 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is -336.00 Billion.